{"entity":{"id":"weiderpass-elisabete","kind":"person","name":"Elisabete Weiderpass","aka":[],"tldr":"Leads the WHO's cancer research agency, which classifies carcinogens and publishes the world's cancer statistics.","summary":"Elisabete Weiderpass is Director of the International Agency for Research on Cancer, the WHO's cancer research agency. A cancer epidemiologist, she has directed IARC since 2019, overseeing the Monographs programme that classifies carcinogens, the GLOBOCAN statistics that report the world's cancer burden, its cohort studies and the WHO Classification of Tumours. Her publications include a review asking whether early-onset cancer is an emerging global epidemic, a worldwide analysis of cervical cancer incidence and mortality, and a description of the Global Breast Cancer Initiative. Her interests span cancer epidemiology, prevention and research leadership.","asOf":"2026-09-08","links":[{"label":"IARC","url":"https://www.iarc.who.int"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Weiderpass%20E%5BAuthor%5D"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":["chemoprevention"],"targets":[],"drugs":[],"companies":[],"institutions":["iarc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["lancet-global-health"],"dependsOn":[],"notes":[],"role":"Director, International Agency for Research on Cancer (WHO)","institutionId":"iarc","specialisms":["Cancer epidemiology","Global cancer burden","Prevention","Research leadership"],"profiles":[{"label":"IARC","url":"https://www.iarc.who.int"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Weiderpass%20E%5BAuthor%5D"}],"papers":[{"title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","journal":"Nature Reviews Clinical Oncology","year":2022,"doi":"10.1038/s41571-022-00672-8"},{"title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","journal":"The Lancet Global Health","year":2020,"doi":"10.1016/s2214-109x(19)30482-6"},{"title":"The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases","journal":"The Lancet Oncology","year":2021,"doi":"10.1016/s1470-2045(21)00071-1"}]},"route":"/people/weiderpass-elisabete/","neighbours":{"technology":[{"id":"chemoprevention","kind":"technology","name":"Chemoprevention & risk-reducing surgery","route":"/technologies/chemoprevention/"}],"institution":[{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"},{"id":"who","kind":"institution","name":"World Health Organization Cancer Programme","route":"/institutions/who/"}],"journal":[{"id":"lancet-global-health","kind":"journal","name":"The Lancet Global Health","route":"/journals/lancet-global-health/"}]}}